Search bioRxiv⌕ Search

Biology subjects

Morison, C.

Publications and source records attributed to Morison, C..

2 recordsLinked to original sources

Stochastic modelling of prostate progenitor architecture

Prostate cancer is a significant global health concern. Experimental and clinical research have contributed to the improvement of treatment outcomes dramatically in the past decade. However, much of the structure of the prostate and its constituent cell types remains unclear: observations of phenotypic switching between basal and luminal cells, as well as intermediate cell types between them, make classifying the components of the prostate an ongoing challenge. Importantly, a tumours cell type of origin seems to play a role in the aggressiveness and genetic heterogeneity of the cancer. To understand how different structures between cell types impact the emergence and treatment of prostate cancer, we model the emergence of a tumour by a fit mutant arising amongst healthy cells via a compartmental modelling approach. We label cells in different compartments based on their phenotype and allow for phenotypic switching between them. We measure the time until and probability of invasion and extinction of this mutant in healthy prostates through individual-based simulations. We find that less-tight population size regulation of the luminal compartment allows for the explosive population growth associated with cancer. Tumours arising in the basal compartment require more time to spread but are more strongly embedded within the prostate, explaining the longer latency and higher aggressiveness and persistence associated with these tumours. Interestingly, the inclusion of a hybrid compartment does not qualitatively change the observations, raising questions as to what mechanistic role intermediate phenotypes play in prostate cancer emergence, if any. Our model contributes to dissecting the relationship between prostate structure and outcomes for cancers arising therein.

evolutionary biology↗

Cancer-immune coevolution dictated by antigenic mutation accumulation

The immune system is one of the first lines of defence against cancer. When effector cells attempt to suppress tumour, cancer cells can evolve methods of escape or inhibition. Knowledge of this coevolutionary system can help to understand tumour-immune dynamics both during tumorigenesis and during immunotherapy treatments. Here, we present an individual-based model of mutation accumulation, where random mutations in cancer cells trigger specialised immune responses. Unlike previous research, we explicitly model interactions between cancer and effector cells and incorporate stochastic effects, which are important for the expansion and extinction of small populations. We find that the parameters governing interactions between the cancer and effector cells induce different outcomes of tumour progress, such as suppression and evasion. While it is hard to measure the cancer-immune dynamics directly, genetic information of the cancer may indicate the presence of such interactions. Our model demonstrates signatures of selection in sequencing-derived summary statistics, such as the single-cell mutational burden distribution. Thus, bulk and single-cell sequencing may provide information about the coevolutionary dynamics.

evolutionary biology↗